Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Daily
19h
GSK Ojjaara approved in Canada for treatment of myelofibrosis in adults who have moderate to severe anemia
Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
Pharmabiz
23h
Health Canada approves GSK’s Ojjaara for the treatment of myelofibrosis in adults who have moderate to severe anaemia
Mississauga, Ontario Thursday, November 14, 2024, 09:00 Hrs [IST] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Tapped for health secretary
Florida sues FEMA officials
OH transgender bathroom bill
Bohannan requests recount
Vonn ending her retirement
Named grand marshal
FBI offering up to $25K
E. coli cases climb to 104
Ben & Jerry's sues Unilever
To close hundreds of stores
Ban on executives upheld
To replace Kotb on 'Today'
Faces up to $165M penalty
Lawyers seek to quit case
Global increase in diabetes
House GOP conference chair
Remains ID'd after 82 years
Briefly detained at airport
EU fines Meta
Seeks pause in docs appeal
Military suicides increased
Notre Dame set to reopen
DOJ report on Fulton jail
FBI raids Coplan's home
Largest coral ever recorded
The Onion buys Infowars
China hacked telecom firms
Israeli airstrikes hit Syria
Judge blocks name change
Bed rails recalled
Teen guilty of swatting calls
Israel accused of war crimes
Related topics
GSK
Health Canada
Ojjaara
GlaxoSmithKline
Feedback